Gregory J Kubicek

Summary

Publications

  1. pmc FDG-PET staging and importance of lymph node SUV in head and neck cancer
    Gregory J Kubicek
    Thomas Jefferson University Hospital, Philadelphia, PA, USA
    Head Neck Oncol 2:19. 2010
  2. pmc Stereotactic body radiotherapy as an alternative to brachytherapy in gynecologic cancer
    Gregory J Kubicek
    Department of Radiation Oncology, Cooper University Hospital, Camden, NJ 08103, USA
    Biomed Res Int 2013:898953. 2013
  3. pmc A gene expression profile test to resolve head & neck squamous versus lung squamous cancers
    Anita Lal
    Pathwork Diagnostics, 595 Penobscot Dr, Redwood City, CA 94063, USA
    Diagn Pathol 8:44. 2013
  4. doi request reprint Chemotherapy in head and neck cancer: clinical predictors of tolerance and outcomes
    Gregory J Kubicek
    Department of Radiation Oncology, University of Pittsburgh Medical Center, PA, USA
    Am J Clin Oncol 34:380-4. 2011
  5. doi request reprint Phase I trial using the proteasome inhibitor bortezomib and concurrent chemoradiotherapy for head-and-neck malignancies
    Gregory J Kubicek
    Department of Radiation Oncology, Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA, USA
    Int J Radiat Oncol Biol Phys 83:1192-7. 2012
  6. ncbi request reprint Target delineation in stereotactic body radiation therapy for recurrent head and neck cancer: a retrospective analysis of the impact of margins and automated PET-CT segmentation
    Kyle Wang
    Department of Radiation Oncology, University of Pittsburg Cancer Institute, Pittsburg, PA, USA
    Radiother Oncol 106:90-5. 2013
  7. doi request reprint Combined transperineal implant and external beam radiation for the treatment of prostate cancer: a large patient cohort in the community setting
    Gregory J Kubicek
    Department of Radiation Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA
    Brachytherapy 10:449-53. 2011
  8. doi request reprint Value of fluoro-2-deoxy-D-glucose-positron emission tomography for detecting metastatic lesions in head and neck cancer
    Shannon E Fogh
    Department of Radiation Oncology, Jefferson Medical College of Thomas Jefferson University, Philadelphia, PA, USA
    Am J Clin Oncol 35:311-5. 2012
  9. pmc A retrospective, deformable registration analysis of the impact of PET-CT planning on patterns of failure in stereotactic body radiation therapy for recurrent head and neck cancer
    Kyle Wang
    Department of Radiation Oncology, University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA
    Head Neck Oncol 4:12. 2012
  10. ncbi request reprint Importance of treatment institution in head and neck cancer radiotherapy
    Gregory J Kubicek
    Department of Radiation Oncology, Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA 19147, USA
    Otolaryngol Head Neck Surg 141:172-6. 2009

Collaborators

Detail Information

Publications15

  1. pmc FDG-PET staging and importance of lymph node SUV in head and neck cancer
    Gregory J Kubicek
    Thomas Jefferson University Hospital, Philadelphia, PA, USA
    Head Neck Oncol 2:19. 2010
    ..The NCCN guidelines do not recommend FDG-PET as a part of standard workup. The purpose of this report is to examine the role of FDG-PET imaging in altering management and providing prognostic information for HNC...
  2. pmc Stereotactic body radiotherapy as an alternative to brachytherapy in gynecologic cancer
    Gregory J Kubicek
    Department of Radiation Oncology, Cooper University Hospital, Camden, NJ 08103, USA
    Biomed Res Int 2013:898953. 2013
    ..However, some patients are unable to tolerate brachytherapy for medical or other reasons. For these patients, stereotactic body radiotherapy (SBRT) offers an alternative form of treatment...
  3. pmc A gene expression profile test to resolve head & neck squamous versus lung squamous cancers
    Anita Lal
    Pathwork Diagnostics, 595 Penobscot Dr, Redwood City, CA 94063, USA
    Diagn Pathol 8:44. 2013
    ..We have developed and validated a gene expression profile test (GEP-HN-LS) that distinguishes HNSCC and lung SCC in formalin-fixed, paraffin-embedded (FFPE) specimens using a 2160-gene classification model...
  4. doi request reprint Chemotherapy in head and neck cancer: clinical predictors of tolerance and outcomes
    Gregory J Kubicek
    Department of Radiation Oncology, University of Pittsburgh Medical Center, PA, USA
    Am J Clin Oncol 34:380-4. 2011
    ..However, little data are available regarding the best chemotherapy agent and dosing, or factors associated with chemotherapy compliance...
  5. doi request reprint Phase I trial using the proteasome inhibitor bortezomib and concurrent chemoradiotherapy for head-and-neck malignancies
    Gregory J Kubicek
    Department of Radiation Oncology, Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA, USA
    Int J Radiat Oncol Biol Phys 83:1192-7. 2012
    ..This Phase I dose-escalation study examined the potential of bortezomib in combination with cisplatin chemotherapy and concurrent radiation in the treatment of locally advanced and recurrent HNC...
  6. ncbi request reprint Target delineation in stereotactic body radiation therapy for recurrent head and neck cancer: a retrospective analysis of the impact of margins and automated PET-CT segmentation
    Kyle Wang
    Department of Radiation Oncology, University of Pittsburg Cancer Institute, Pittsburg, PA, USA
    Radiother Oncol 106:90-5. 2013
    ..We assessed the impact of retrospectively adding margins/automated PET volumes to the gross tumor volume (GTV) in patients with post-SBRT recurrences...
  7. doi request reprint Combined transperineal implant and external beam radiation for the treatment of prostate cancer: a large patient cohort in the community setting
    Gregory J Kubicek
    Department of Radiation Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA
    Brachytherapy 10:449-53. 2011
    ..Our purpose was to report the results of combined modality therapy from a single institution in the community setting...
  8. doi request reprint Value of fluoro-2-deoxy-D-glucose-positron emission tomography for detecting metastatic lesions in head and neck cancer
    Shannon E Fogh
    Department of Radiation Oncology, Jefferson Medical College of Thomas Jefferson University, Philadelphia, PA, USA
    Am J Clin Oncol 35:311-5. 2012
    ..The purpose of this report is to examine the accuracy of staging PET scans for detecting distant metastatic disease in patients with HNC...
  9. pmc A retrospective, deformable registration analysis of the impact of PET-CT planning on patterns of failure in stereotactic body radiation therapy for recurrent head and neck cancer
    Kyle Wang
    Department of Radiation Oncology, University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA
    Head Neck Oncol 4:12. 2012
    ..We analyzed the patterns of failure following SBRT for rSCCHN and assessed the impact of PET-CT treatment planning on these patterns of failure...
  10. ncbi request reprint Importance of treatment institution in head and neck cancer radiotherapy
    Gregory J Kubicek
    Department of Radiation Oncology, Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA 19147, USA
    Otolaryngol Head Neck Surg 141:172-6. 2009
    ..Our goal is to determine if these potential AC advantages correspond to a difference in treatment outcome...
  11. doi request reprint New advances in high-technology radiotherapy for head and neck cancer
    Gregory J Kubicek
    Department of Radiation Oncology, Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA 19107, USA
    Hematol Oncol Clin North Am 22:1165-80, viii. 2008
    ..Some of these advances are discussed in this article...
  12. doi request reprint Do elderly patients experience increased perioperative or postoperative morbidity or mortality when given neoadjuvant chemoradiation before esophagectomy?
    Shannon E Fogh
    Department of Radiation Oncology, University of California, San Francisco, CA 94143, USA
    Int J Radiat Oncol Biol Phys 80:1372-6. 2011
    ....
  13. pmc Phase I trial using proteasome inhibitor bortezomib and concurrent temozolomide and radiotherapy for central nervous system malignancies
    Gregory J Kubicek
    Department of Radiation Oncology, Jefferson Medical College of Thomas Jefferson University, Philadelphia, PA, USA
    Int J Radiat Oncol Biol Phys 74:433-9. 2009
    ..To evaluate the toxicity and response rate of bortezomib with concurrent radiotherapy and temozolomide in the treatment of patients with central nervous system malignancies...
  14. doi request reprint The role of cetuximab in the management of head and neck cancers
    Peyman Kabolizadeh
    University of Pittsburgh Cancer Institute, Department of Radiation Oncology, Pittsburgh, PA 15232, USA
    Expert Opin Biol Ther 12:517-28. 2012
    ..Cetuximab is a chimeric mAb directed against the EGFR that showed clinical activity in squamous cell carcinoma of head and neck (SCCHN)...
  15. doi request reprint PSA decrease during combined-modality radiotherapy predicts for treatment outcome
    Gregory J Kubicek
    Department of Radiation Oncology, Jefferson Medical College of Thomas Jefferson University, Philadelphia, PA, USA
    Int J Radiat Oncol Biol Phys 78:759-62. 2010
    ..Although reports have focused on the importance of pretreatment PSA levels, doubling time, and posttreatment nadirs, there is little information on the value of PSA during the course of radiotherapy...